Informações:
Falhas:
ID
34306
Descrição
Vitamin D Supplementation for Treatment of Heart Failure; ODM derived from: https://clinicaltrials.gov/show/NCT01230307
Link
https://clinicaltrials.gov/show/NCT01230307
Palavras-chave
Versões (1)
- 16/01/2019 16/01/2019 -
Titular dos direitos
GSK group of companies
Transferido a
16 de janeiro de 2019
DOI
Para um pedido faça login.
Licença
Creative Commons BY-NC 3.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Heart Failure NCT01230307
Eligibility Heart Failure NCT01230307
- StudyEvent: Eligibility
Similar models
Eligibility Heart Failure NCT01230307
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
ID.1
Item
hf patients with lv systolic dysfunction of ischemic or non-ischemic origin and an lvef <40% using nuclear ventriculography or echocardiography within the last 6 months.
boolean
ID.2
Item
attempts should have been made at optimizing medical therapy and the participant should be stable on these medications for at least 3 months.
boolean
ID.3
Item
patients with a 25(oh)d level between 10-25 ng/ml
boolean
ID.4
Item
inability to give informed consent
boolean
ID.5
Item
patients with sarcoidosis or other granulomatous disease that can alter vitamin d metabolism
boolean
ID.6
Item
patients with primary valvular hf, hypertrophic cardiomyopathy, and drug-induced hf
boolean
ID.7
Item
renal dysfunction defined as serum creatinine > 2.5 mg/dl
boolean
ID.8
Item
pregnant women
boolean
ID.9
Item
patients <18 years of age
boolean
ID.10
Item
patients on vitamin d supplementation
boolean